Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:1558-1565
Published online before print May 30, 2008, doi: 10.1161/CIRCRESAHA.108.176990
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/12/1558    most recent
CIRCRESAHA.108.176990v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Dabir, P.
Right arrow Articles by Stenina, O. I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dabir, P.
Right arrow Articles by Stenina, O. I.
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Other diabetes
Right arrow Glucose intolerance
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2008;102:1558.)
© 2008 American Heart Association, Inc.


Molecular Medicine

Aryl Hydrocarbon Receptor Is Activated by Glucose and Regulates the Thrombospondin-1 Gene Promoter in Endothelial Cells

Pankaj Dabir, Tina E. Marinic, Irene Krukovets, Olga I. Stenina

From the Department of Molecular Cardiology, Cleveland Clinic, Ohio.

Correspondence to Olga I. Stenina, 9500 Euclid Ave, NB50-66, Cleveland, OH 44195. E-mail stenino{at}ccf.org

Hyperglycemia is an independent risk factor for development of diabetic vascular complications. The molecular mechanisms that are activated by glucose in vascular cells and could explain the development of vascular complications are still poorly understood. A putative binding site for the transcription factor aryl hydrocarbon receptor (AhR) was identified in the glucose-responsive fragment of the promoter of thrombospondin-1, a potent antiangiogenic and proatherogenic protein involved in development of diabetic vascular complications. AhR was expressed in aortic endothelial cells (ECs), activated, and bound to the promoter in response to high glucose stimulation of ECs. The constitutively active form of AhR induced activation of the thrombospondin-1 gene promoter. In response to high glucose stimulation, AhR was found in complex with Egr-1 and activator protein-2, which are 2 other nuclear transcription factors activated by glucose in ECs that have not been previously detected in complex with AhR. The activity of the DNA-binding complex was regulated by glucose through the activation of hexosamine pathway and intracellular glycosylation. This is the first report of activation of AhR (a receptor for xenobiotic compounds) by a physiological stimulus. This report links the activation of AhR to the pathological effects of hyperglycemia in the vasculature.


Key Words: aryl hydrocarbon receptor • glucose • thrombospondin-1 • endothelial cells